Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
7%
OVERLAP
BY WEIGHT
4
# OF OVERLAPPING
HOLDINGS
HART
69
HOLDINGS
7%
ALSO IN XPH
XPH
60
HOLDINGS
7%
ALSO IN HART
SECTOR DRIFT (HART minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 7.5% | 1.9% | 1.9% |
|
JOHNSON & JOHNSON | 7.5% | 1.6% | 1.6% |
|
PFIZER INC | 5.4% | 1.6% | 1.6% |
|
BRISTOL-MYERS SQUIBB CO | 3.6% | 1.6% | 1.6% |
HART Overweight Relative to XPH
|
APPLE INC | 7.5% |
|
UNITEDHEALTH GROUP INC | 6.7% |
 |
NOVARTIS AG | 6.5% |
 |
ASTRAZENECA PLC | 6.1% |
|
JOHNSON & JOHNSON | 5.8% |
|
ALPHABET INC. CLASS A | 5.8% |
|
ELI LILLY & CO | 5.6% |
|
PFIZER INC | 3.8% |
 |
MEDTRONIC PLC | 3.4% |
|
ABBOTT LABORATORIES | 3.4% |
HART Underweight Relative to XPH
|
CORCEPT THERAPEUTICS INC | -4.1% |
|
ORGANON & CO. | -3.6% |
|
LIQUIDIA TECHNOLOGIES, INC. | -3.2% |
|
AXSOME THERAPEUTICS, INC. | -2.7% |
|
ENLIVEN THERAPEUTICS, INC. | -2.5% |
|
MBX BIOSCIENCES INC | -2.5% |
|
TREVI THERAPEUTICS, INC. | -2.5% |
|
DEFINIUM THERAPEUTICS INC | -2.3% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.2% |
|
LIGAND PHARMACEUTICALS-CL B | -2.1% |